Adamas Pharma secures approval for Parkinson's dyskinesia drug

  1. Adamas Pharma secures approval for Parkinson's dyskinesia drug  Reuters
  2. US OKs first drug for dyskinaesia in Parkinson's patients  PharmaTimes
  3. Adamas Pharma (ADMS) Reports FDA Approval of GOCOVRI for Treatment of Dyskinesia in Parkinson's Disease ...  StreetInsider.comFull coverage

posted from Health - Google News
Thank you for reading the Adamas Pharma secures approval for Parkinson's dyskinesia drug on Syria News Kit If you want to spread this News please include links as Source, and if this News useful please bookmark this page in your web browser, by pressing Ctrl + D on your keyboard button, Or click the share button to place it on your profile.

Latest news:

Note: Only a member of this blog may post a comment.